Amalgamated Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Hold |
622
| – | – | ﹤0.01% | 1565 |
|
|
2025
Q1 | $206K | Buy |
622
+15
| +2% | +$4.97K | ﹤0.01% | 1529 |
|
|
2024
Q4 | $187K | Hold |
607
| – | – | ﹤0.01% | 1593 |
|
|
2024
Q3 | $129K | Hold |
607
| – | – | ﹤0.01% | 1660 |
|
|
2024
Q2 | $170K | Buy |
607
+102
| +20% | +$28.6K | ﹤0.01% | 1618 |
|
|
2024
Q1 | $135K | Sell |
505
-1,614
| -76% | -$431K | ﹤0.01% | 1676 |
|
|
2023
Q4 | $490K | Buy |
2,119
+57
| +3% | +$13.2K | ﹤0.01% | 1456 |
|
|
2023
Q3 | $301K | Buy |
2,062
+29
| +1% | +$4.23K | ﹤0.01% | 1628 |
|
|
2023
Q2 | $470K | Buy |
2,033
+229
| +13% | +$52.9K | ﹤0.01% | 1469 |
|
|
2023
Q1 | $437K | Sell |
1,804
-292
| -14% | -$70.7K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $608K | Buy |
2,096
+47
| +2% | +$13.6K | 0.01% | 1375 |
|
|
2022
Q3 | $133K | Buy |
2,049
+30
| +1% | +$1.95K | ﹤0.01% | 2014 |
|
|
2022
Q2 | $145K | Buy |
2,019
+100
| +5% | +$7.18K | ﹤0.01% | 2017 |
|
|
2022
Q1 | $188K | Buy |
+1,919
| New | +$188K | ﹤0.01% | 1965 |
|
|
2021
Q3 | – | Sell |
-2,145
| Closed | -$209K | – | 2174 |
|
|
2021
Q2 | $209K | Buy |
+2,145
| New | +$209K | ﹤0.01% | 2016 |
|
|
2018
Q3 | – | Sell |
-888
| Closed | -$248K | – | 1550 |
|
|
2018
Q2 | $248K | Buy |
+888
| New | +$248K | 0.01% | 1440 |
|